Browsing by Project
AstraZeneca Pharmaceuticals LP
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) | Type | Мp-cat. |
| 2019 | Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial | Hochman, Judith S; ...; Beleslin, Branko D   ; Cemerlic-Adjic, Nada B; ...; Stankovic, Goran R ; Apostolovic, Svetlana R ; ...; (broj, koautora 433) | Article | |
| 2023 | Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial | Borlaug, Barry A; Reddy, Yogesh NV; Braun, Amanda; Sorimachi, Hidemi; Omar, Massar; Popovic, Dejana R; Alogna, Alessio; Jensen, Michael D; Carter, Rickey | Article | |
| 2025 | Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop | Barnard, Kelly Katharine; ...; Lalic, Nebojsa M; ...; (broj, koautora 26) | Article | |
| 2024 | Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshop | Gavin, James R; ...; Lalic, Nebojsa M; ...; (broj, koautora 22) | Article | |
| 2026 | From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce | Wanner, Christoph; ...; Lalic, Nebojsa; ...; (broj, koautora 27) | Article | |